This article makes much more sense of the issue. It is just that a test to diagnose ovarian cancer not to cure it!
Clinicians need to firstly understand whether a person has it and this test is more reliable than CA-125 test. This has already been proved in clinically controlled tests and will shortly will be further validated by a huge international study which will seek to further improve the accuracy of the result to 98% by introduction of 2 biomarkers.
Not sure whether some politics going on with National Cancer Centre etc....usually what you see with this sort of tabloid rubbish....speaking to those who noses are out of joint or want to feel more self important than they are...
Short term buying opportunity for my mind so grabbed some today with view will top up further as fallout from article continues.
Rice summed it up to my mind as a load of codswallop....
HTX Price at posting:
8.9¢ Sentiment: LT Buy Disclosure: Held
